Lanthanide-Doped Upconversion Nanoparticles: Emerging Intelligent Light-Activated Drug Delivery Systems

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Materials Science

Background:

• Upconversion nanoparticles (UCNPs) enable drug delivery systems (DDSs) activated by near-infrared (NIR) light.
• NIR light offers superior tissue penetration and reduced phototoxicity compared to high-energy wavelengths.
• Current research aims to develop DDSs activated by low-intensity NIR illumination to minimize thermal damage in vivo.

Purpose of the Study:

• To review recent advancements in NIR-initiated DDS development.
• To highlight the use of photo-responsive compounds and polymeric materials conjugated onto UCNPs.
• To discuss challenges and strategies for clinical translation of UCNP-based DDSs.

Main Methods:

• Focus on UCNPs with enhanced quantum yield.
• Incorporation of photo-responsive materials with red-shifted absorption into UCNPs.
• Tuning of UCNP excitation wavelengths for optimal NIR activation.

Main Results:

• NIR-initiated DDSs provide high spatial and temporal control over drug release.
• UCNP-based platforms offer advantages in tissue penetration and reduced cellular damage.
• Strategies for overcoming limitations in UCNP clinical applications are being developed.

Conclusions:

• NIR-initiated DDSs using UCNPs represent a promising frontier in targeted therapeutics.
• Continued research into UCNP enhancement and functionalization is crucial for clinical viability.
• Optimizing NIR activation and material conjugation will enhance the safety and efficacy of these advanced drug delivery systems.